These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 20375212

  • 1. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
    Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
    [Abstract] [Full Text] [Related]

  • 2. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [Abstract] [Full Text] [Related]

  • 3. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
    Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.
    Metabolism; 2012 May; 61(5):706-14. PubMed ID: 22136911
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance predicts steatosis and fibrosis in morbidly obese patients undergoing bariatric surgery.
    Aller R, de Luis D, Pacheco D, Velasco MC, Izaola O, Sagrado MG.
    J Investig Med; 2012 Oct; 60(7):1005-8. PubMed ID: 22847342
    [Abstract] [Full Text] [Related]

  • 5. Serum chemerin and vaspin in non-alcoholic fatty liver disease.
    Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R.
    Scand J Gastroenterol; 2010 Oct; 45(2):235-42. PubMed ID: 20095887
    [Abstract] [Full Text] [Related]

  • 6. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy.
    Terra X, Auguet T, Guiu-Jurado E, Berlanga A, Orellana-Gavaldà JM, Hernández M, Sabench F, Porras JA, Llutart J, Martinez S, Aguilar C, Del Castillo D, Richart C.
    Obes Surg; 2013 Nov; 23(11):1790-8. PubMed ID: 23832521
    [Abstract] [Full Text] [Related]

  • 7. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
    Habib SS, Eshki A, AlTassan B, Fatani D, Helmi H, AlSaif S.
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
    [Abstract] [Full Text] [Related]

  • 8. Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention.
    Niklowitz P, Rothermel J, Lass N, Barth A, Reinehr T.
    Int J Obes (Lond); 2018 Oct; 42(10):1743-1752. PubMed ID: 30030480
    [Abstract] [Full Text] [Related]

  • 9. Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.
    Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC, Moody FG, Lux TR, Taegtmeyer H.
    Am J Med; 2009 May; 122(5):435-42. PubMed ID: 19375553
    [Abstract] [Full Text] [Related]

  • 10. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S, Wang Q, Huang W, Song Y, Feng G, Zhou L, Tan J.
    Gynecol Endocrinol; 2016 May; 32(1):38-41. PubMed ID: 26291816
    [Abstract] [Full Text] [Related]

  • 11. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance.
    Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A.
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2307-12. PubMed ID: 18334587
    [Abstract] [Full Text] [Related]

  • 12. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women.
    Auguet T, Terra X, Hernández M, Sabench F, Porras JA, Orellana-Gavaldà JM, Llutart J, Guiu-Jurado E, Berlanga A, Martinez S, Aguilar C, Castillo DD, Richart C.
    Obesity (Silver Spring); 2014 Jan; 22(1):188-94. PubMed ID: 23554365
    [Abstract] [Full Text] [Related]

  • 13. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL, Lee WJ, Wang W, Lee YC, Chen WY, Fang CL, Huang MT.
    Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
    [Abstract] [Full Text] [Related]

  • 14. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients.
    Jankiewicz-Wika J, Kołomecki K, Cywiński J, Piestrzeniewicz K, Swiętosławski J, Stępień H, Komorowski J.
    Endokrynol Pol; 2011 Jul; 62(2):109-19. PubMed ID: 21528472
    [Abstract] [Full Text] [Related]

  • 15. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery.
    Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J.
    World J Surg; 2011 Sep; 35(9):2022-30. PubMed ID: 21691870
    [Abstract] [Full Text] [Related]

  • 16. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
    Argentou M, Tiniakos DG, Karanikolas M, Melachrinou M, Makri MG, Kittas C, Kalfarentzos F.
    Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638
    [Abstract] [Full Text] [Related]

  • 17. Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.
    Alfadda AA, Sallam RM, Chishti MA, Moustafa AS, Fatma S, Alomaim WS, Al-Naami MY, Bassas AF, Chrousos GP, Jo H.
    Mol Cells; 2012 Jun; 33(6):591-6. PubMed ID: 22544171
    [Abstract] [Full Text] [Related]

  • 18. Plasma chemerin in young untrained men: association with cardio-metabolic traits and physical performance, and response to intensive interval training.
    Ouerghi N, Fradj MKB, Khammassi M, Feki M, Kaabachi N, Bouassida A.
    Neuro Endocrinol Lett; 2017 Feb; 38(1):59-66. PubMed ID: 28456149
    [Abstract] [Full Text] [Related]

  • 19. Circulating Soluble IL-6 Receptor Concentration and Visceral Adipocyte Size Are Related to Insulin Resistance in Taiwanese Adults with Morbid Obesity.
    Kuo FC, Huang YH, Lin FH, Hung YJ, Hsieh CH, Lu CH, Su SC, Huang CL, Lee CH, Chu NF.
    Metab Syndr Relat Disord; 2017 May; 15(4):187-193. PubMed ID: 28346858
    [Abstract] [Full Text] [Related]

  • 20. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
    Wang LY, Wei L, Yu HY, Zhang Y, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 03; 89(4):235-8. PubMed ID: 19552838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.